Skip to content

Genetic analysis for specific CDT (Cystinotic Disease Transcriptome) variants using qualitative probe-based next-generation sequencing

Published: August 9, 2026Updated: August 16, 2026

This test checks for genetic changes linked to a rare inherited disorder called cystinosis, using a specialized DNA analysis method.

Quick summary

["This test helps diagnose or monitor genetic conditions affecting cystine storage in cells."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
53943-7
Short code
CDTG
Synonyms
cdt gene Spec Ql NAA+probe
Category
chemistry
Sample
serum
Container
Sterile, leak-proof container (preferred) or serum separator tube (SST) for serum specimens
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
CPT
87798
SNOMED
39823008
Specimen volume
1-2 mL serum
Stability
Refrigerated (2-8°C): 7 days; Frozen (-70°C or below): 30 days; Room temperature: 24 hours
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
24–72 hours
Order
routine

What This Test Measures

The test detects specific genetic mutations (variants) associated with cystinosis, a condition where the body cannot properly break down a protein called cystine. These mutations are identified through a targeted genetic probe analysis of your DNA.

Why It’s Done

Your healthcare provider may recommend this test if you have symptoms of cystinosis (e.g., kidney problems, fatigue, or eye issues) or if you have a family history of the disorder. It can also be used for prenatal testing or carrier screening in certain situations.

Sample Collection

A blood sample is typically taken from you. The blood is processed to extract DNA, which is then analyzed for the targeted genetic variants using a specialized probe-based method.

How Results Are Used

Results help confirm a diagnosis of cystinosis, guide treatment decisions, or determine if you’re a carrier of the genetic mutation. This information can influence long-term management plans, including dietary or medical interventions.

Reference range

Negative (Target cdt gene not detected)N/A

Specimen: serum

No special patient preparation required. Specimen should be collected prior to initiation of antimicrobial therapy when clinically feasible.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

None

Frequently asked questions

How long will it take to get my results?
Results are usually available within 2–4 weeks, depending on lab processing times and any additional confirmatory testing required.
What if my test results are abnormal?
If abnormal results are found, your healthcare provider will discuss next steps, which may include additional genetic testing, specialist referrals, or monitoring plans tailored to your needs.
Does this test require fasting?
No fasting is required for this genetic test. Your sample is collected from a simple blood draw, and results focus on genetic information rather than blood chemistry levels.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy